Human Liver Cancer Cell HUH-7 Transfection Kit
| Kit size Volume | Quantity | ||
|---|---|---|---|
| 0.5 ml(Cat-177554) | Inquiry | Add to cart | |
| 1.5 ml(Cat-177655) | Inquiry | Add to cart | |
| 8.0 ml(Cat-177757) | Inquiry | Add to cart | |
| 1.5 ml CRISPR(Cat-215856) | Inquiry | Add to cart |
Description
Product Information
Modes of administration
Reagent exhibits at least 88% transfection efficiency of siRNA delivery. Transfection efficiency was determined by qRT-PCR.
Description
Huh7 is a type of human liver cancer cell that was initially taken from a patient who had hepatitis C virus infection. These cells are extensively used in liver cancer research to study different aspects of HCC biology, such as cell proliferation, apoptosis, migration, invasion, and drug resistance. It's essential to diagnose liver cancer early as it has a higher chance of complete remission and survival. If detected early, the five-year survival rate of liver cancer is 50%, compared to only 3% if it spreads to other organs. HuH-7 cells are a type of well-differentiated tumorigenic liver cells that are useful for transfection studies. They were derived from a liver tumor of a 57-year-old Japanese male patient in 1982. These cells have an epithelial cell morphology and are immortal. The HuH-7 cell line is frequently used in liver cancer research, where the cancer is usually caused by viral hepatitis or cirrhosis. CD BioSciences offers polymer-based biodegradable transfection reagents that can be used for the HuH-7 hepatoma cell line.
